Results 151 to 158 of about 47,015 (158)

Metabolic-immune microenvironment crosstalk mediating ICI resistance in MASH-HCC

Trends in Endocrinology and Metabolism
Yufeng Yuan, Kequan Xu
exaly  

Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes

Journal of Hepatology
Anaı̈S Vallet-Pichard
exaly  

The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC

Frontiers in Immunology
Yihe Yan, David Geller
exaly  

Understanding MASH: An Examination of Progression and Clinical Outcomes by Disease Severity in the TARGET-NASH Database

Advances in Therapy
Rakesh Luthra
exaly  

From MASH to HCC: the role of Gas6/TAM receptors

Frontiers in Immunology
Mario Pirisi, Barbara Ferrari, Rosalba Minisini   +2 more
exaly  

THE EFFECTS OF MASHING TEMPERATURE AND MASH THICKNESS ON WORT CARBOHYDRATE COMPOSITION

Journal of the Institute of Brewing, 1991
exaly  

ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH

Journal of Hepatology
Xiaoxu Li, Angelique Scantlebery, Johan Auwerx   +2 more
exaly  

Targeting PNPLA3 to Treat MASH and MASH Related Fibrosis and Cirrhosis

Liver International
Rohit Loomba, Daniel Linden, Gregory Tesz   +2 more
exaly